Financial Toxicity in Neuromyelitis Optica Spectrum Disorder: An ABC-X Mixed-Methods Study. [PDF]
Wang B +6 more
europepmc +1 more source
Seronegative Neuromyelitis Optica Spectrum Disorder in a Six-Year-Old Patient: A Case Report. [PDF]
Pinacho-Velázquez JL +4 more
europepmc +1 more source
Cellular therapy in neuromyelitis optica spectrum disorder. [PDF]
Zhong K, Tang Y.
europepmc +1 more source
Glymphatic dysfunction in neuromyelitis optica spectrum disorder. [PDF]
Zhang Y +8 more
europepmc +1 more source
Persistent Pathological Yawning due to Neuromyelitis Optica Spectrum Disorder. [PDF]
Saroja AO, Naik KR.
europepmc +1 more source
Longitudinal Spinal Cord Atrophy in Patients With Neuromyelitis Optica Spectrum Disorder and Its Association With Rituximab Treatment. [PDF]
Yao Y +16 more
europepmc +1 more source
Differences in disease burden between neuromyelitis optica spectrum disorder and multiple sclerosis in South China. [PDF]
Huang X, Feng H, Li J, Fan Y, Zeng J.
europepmc +1 more source
Pseudoathetotic Pseudodystonia as a Manifestation of Isolated Medullary Demyelination in Neuromyelitis Optica Spectrum Disorder. [PDF]
Mohapatra P +8 more
europepmc +1 more source
Global landscape of neuromyelitis optica spectrum disorder clinical trials: trends in therapies, geography, and outcomes. [PDF]
Wang G +7 more
europepmc +1 more source
Cognitive Impairment and Quality of Life in AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study in Iranian Patients. [PDF]
Ramazanzadeh S, Ashtari F.
europepmc +1 more source

